Trial Profile
A Double-blind, Randomized, Placebo-controlled Phase IV Clinical Study of the Efficacy and Safety of a New Formulation of Paracetamol for the Management of Fever of Infectious Origin
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Apr 2016
Price :
$35
*
At a glance
- Drugs Paracetamol (Primary)
- Indications Fever
- Focus Therapeutic Use
- Sponsors Unipharma
- 21 Mar 2016 Status changed from recruiting to completed, according to ClinicalTrials.gov record.
- 07 Dec 2015 Planned End Date changed from 1 Jul 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov
- 07 Dec 2015 Planned primary completion date changed from 1 Jun 2015 to 1 Mar 2016 as reported by ClinicalTrials.gov